Investigations and Cases

The Infectious Diseases & Outbreaks Division monitors the incidence and prevalence of communicable, zoonotic, and environmentally-related human diseases. This table summarizes cases reported over the last five years, as well as the cases reported year-to-date this year and last year.

 

Cases Reported Year-to-Date*

Totals by Year Reported

Condition

2017

2016

% Change

2016

2015

2014

2013

2012

Anthrax

0

0

--

0

0

0

0

0

Arboviral Diseases (includes West Nile virus, Zika virus, and other Arboviral diseases)

60

57

5.3%

60^

10^

23^

11

62

Babesiosis

1

0

--

0

2

1

0

0

Botulism

0

1

-100.0%

1

1

0

0

0

Brucellosis

0

0

--

0

2

0

1

0

Campylobacteriosis

750

647

15.9%

692

589^

255

232

243

Cholera

0

0

--

0

0

0

0

0

Cryptosporidiosis

174

318

-45.3%

334

261

147

144

109

Dengue

0

5

-100.0%

5

3^

3

5

4

E. coli, shiga toxin-producing (includes O157: H7)

29

37

-21.6%

39

40

41^

53

64

Ehrlichiosis/Anaplasmosis

17

21

-19.0%

21

18

19

15

26

Giardiasis

175

225

-22.2%

234

188

182

174

178

Hansen's Disease (Leprosy)

0

1

-100.0%

1

1

0

1^

1

Hemolytic uremic syndrome (HUS)

0

5

-100.0%

6

3

1

2

7

Hepatitis E, acute

1

0

--

0

0

0

0

0

Influenza-associated pediatric mortality

1

0

--

0

1

1

1

0

Legionellosis

64

57

12.3%

63

59

62

41

20

Leptospirosis

0

0

--

0

0

1

1^

0

Listeriosis

4

7

-42.9%

8

5

9

5

10

Lyme disease

37^

38

-2.6%

38

25

17

24

25

Malaria

8

10

-20.0%

11

11

14^

2

10

Novel Influenza A virus infection

0

0

--

0

0

0^

0^

0

Plague

0

0

--

0

0

0

0

0

Psittacosis

0

0

--

0

0

0

0

0

Q fever

0

1

-100.0%

1

0

2

2

0

Rabies, animal

48

74

-35.1%

77

83

78

39

--

Rabies, human

0

0

--

0

0

0

0

0

Salmonellosis

990^

1215

-18.5%

1285

1151

1165

1087

1150

Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV)

0

0

--

0

0

0

0

0

Shigellosis

198^

233

-15.0%

239

680

516

313

331

Spotted Fever Rickettsiosis

639

445

43.6%

453

288

220

255

167

Trichinellosis (Trichinosis)

0

0

--

0

0

0^

0

0

Tularemia

1^

1

0.0%

1

0

0

0

0

Typhoid fever

1

0

--

0

0

2

4

1

VISA (Staphylococcus aureus, vancomycin-intermediate)

4

3

33.3%

3

2

2

0

1

VRSA (Staphylococcus aureus, vancomycin-resistant)

0

0

--

0

0

0

0

0

Vibriosis (non-Cholera)

24^

30

-20.0%

31

19

20

18

20

Yellow Fever

0

0

--

0

0

0

0

0

Other Investigations

0

0

--

0

0

27

29

19

Total

3226

3431

-6.0%

3543

2840

2730

2457

2448

NOTE: Counts include finalized investigations among Alabama residents as of December 15, 2017. The Other investigations category includes a variety of conditions or events that have been investigated, but are not reportable in Alabama or do not fall into any other category (e.g., Acute flaccid myelitis, Histoplasmosis, Staphylococcal toxic-shock syndrome, Yersiniosis, etc.). To see case counts for conditions investigated by other divisions, please see the following websites: Tuberculosis, Immunizations, Sexually Transmitted Diseases, and HIV/AIDS.

*As of MMWR Week 49 (week ending December 9, 2017) 

^The case definition was updated this year for this condition.

 

 


Page last updated: December 15, 2017